Navigation Links
Royalty Pharma Announces that James Reddoch, Ph.D., Joins Management Team
Date:7/8/2008

NEW YORK, July 8 /PRNewswire/ -- Royalty Pharma is pleased to announce that James Reddoch, Ph.D., has joined the company as Executive Vice President, Head of Research. Dr. Reddoch has 17 years of experience in the biotechnology sector. He has spent the last 12 years as an equity analyst, most recently as Managing Director, Biotechnology and Group Head, Healthcare, at FBR Capital Markets. He previously worked at Banc of America Securities, and CIBC World Markets Corp. (now Oppenheimer & Co.). Dr. Reddoch holds a B.A. from Furman University and a Ph.D. in Biochemistry and Molecular Genetics from the University of Alabama at Birmingham. He was a postdoctoral fellow at the Yale University School of Medicine.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061026/RPLOGO )

"The addition of Jim to our management team adds a critical element to our analytical capabilities. He combines a deep scientific knowledge with fundamental research and financial skills," said Pablo Legorreta, Chief Executive Officer of Royalty Pharma. "As an analyst, Dr. Reddoch has proven to have a unique perspective that has differentiated him from his peers."

About Royalty Pharma

Royalty Pharma is the industry leader in acquiring revenue-producing intellectual property -- principally royalty interests in marketed and late stage biopharmaceutical products with approximately $5 billion in assets. Royalty Pharma currently owns a diversified portfolio of royalty interests in several high-quality blockbuster biopharmaceutical products, including Abbott's Humira(R), J&J/Centocor's Remicade(R), Pfizer's Lyrica(R), Amgen's Neupogen(R) and Neulasta(R), Genentech's Rituxan(R), Gilead's Emtriva(R), Truvada(R) and Atripla(R), and Celgene's Thalomid(R).

The company has an eleven year history of providing value to holders of royalty interests, including its $700 million purchase of the Lyrica(R)
'/>"/>

SOURCE Royalty Pharma
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Angiotech to Establish Separate Operating and Royalty Businesses
2. Neurobiological Technologies Reports Receipt of $2.0 Million Royalty Payment for Quarterly Sales of Memantine
3. Royalty Pharma Acquires Royalty Interest in RotaTeq(R) from The Childrens Hospital Foundation for $182 Million
4. CV Therapeutics Announces $185 Million Transaction with TPG-Axon Capital for Half of Royalty for Lexiscan(TM) (regadenoson) Injection
5. Antibody Engineering Company F-Star Buys Back Royalty Obligations
6. Cowen Group, Inc. and Cowen Healthcare Royalty Partners Announce Expansion of Royalty Investment Team
7. Cowen Group, Inc. and Cowen Healthcare Royalty Partners Announce Expansion of Royalty Investment Team
8. Drug Royalty Corporation Changes Its Name to DRI Capital
9. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
10. Pharmaceutical Institute, in Collaboration With Campbell Alliance, Releases Second Edition of Breakthrough Book on the Inner Workings of the Pharmaceutical Industry
11. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... 2014 The 20 ambassadors representing the ... community issued the following statement on Facebook today regarding ... driving new funding specifically for ALS research: , “Who ... some ice would raise all this awareness and funding ... and on behalf of the entire ALS community, would ...
(Date:8/26/2014)... 26, 2014  ViveBio, LLC a leading provider ... and transportation, announced today that it has signed ... (LPS) of Knoxville, Tennessee ... the United States . ViveST is ... temperature dried biological specimen transport systems.  The technology ...
(Date:8/26/2014)... Genedata, a leading provider of advanced ... research, today announced the Genedata Screener® Global ... Asia, Europe, and North America during September 2014. ... research organizations will gather for annual User Group ... upcoming challenges in all areas of screening. This ...
(Date:8/26/2014)... Aug. 26, 2014 Albany Molecular Research Inc. ... William S. Marth , President and Chief Executive Officer ... Healthcare Conference on Monday, September 8, 2014 at 8:45 ... of the presentation can be accessed at AMRI,s Investor ... The webcast will be archived for 90 days following ...
Breaking Biology Technology:ALS TDI’s Young Faces of ALS Ambassadors Thank You for Accepting the Ice Bucket Challenge to End ALS 2ALS TDI’s Young Faces of ALS Ambassadors Thank You for Accepting the Ice Bucket Challenge to End ALS 3ALS TDI’s Young Faces of ALS Ambassadors Thank You for Accepting the Ice Bucket Challenge to End ALS 4ViveBio and Laboratory Procurement Services Sign Agreement for Distribution of the ViveST Line of Products 2Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 2Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 3
... . . . Researchers at Oak Ridge ... extruding aluminum-based wire in lengths up to 15 feet. ... method that uses the heat from a spinning tool ... recycling. The ORNL researchers optimized the friction-stir process to ...
... 2011 Biocept, Inc., a privately-held laboratory testing ... of circulating tumor cells (CTCs) in cancer patients, ... the identification of different CTC phenotypes using its ... paper, appearing in the Journal of Oncology ...
... May 10, 2011 The Laboratory Department for ... of Medicine (NAGATA Satoru, YAMASHIRO Yuichiro et al.) ... casei strain Shirota (LcS) in elderly individuals living ... associated with acute norovirus gastroenteritis. ...
Cached Biology Technology:Story tips from the Department of Energy's Oak Ridge National Laboratory 2Biocept Demonstrates Multiple Phenotypes of Circulating Tumor Cells (CTCs) in Cancer Patients 2Biocept Demonstrates Multiple Phenotypes of Circulating Tumor Cells (CTCs) in Cancer Patients 3Lactobacillus Beverage Confirmed to Reduce Fever Brought on by Acute Gastroenteritis Caused by Norovirus Infection 2Lactobacillus Beverage Confirmed to Reduce Fever Brought on by Acute Gastroenteritis Caused by Norovirus Infection 3
(Date:8/25/2014)... in the biofuels industry: "You can make anything ... study may pave the way to challenging that ... Renewable Energy Laboratory (NREL) demonstrates a concept that ... into a variety of renewable fuels, chemicals, and ... Lignin Valorization Through Integrated Biological Funneling and Chemical ...
(Date:8/25/2014)... effects of substances known as endocrine disrupting chemicals ... can pass from one generation to the next, ... exposure to EDC may show especially adverse reactions ... by researchers from The University of Texas at ... rats are affected differently by ancestral exposure to ...
(Date:8/25/2014)... report that there are 133 active fires in the North ... reported in the past 24 hours. Fire danger is moderate ... communities. , The Birch Lake Complex of fires are in ... to within 30 km north of Fort Providence. Four ... at Moraine Point this week. Mop-up continues many areas of ...
Breaking Biology News(10 mins):New process helps overcome obstacles to produce renewable fuels and chemicals 2Exposure to toxins makes great granddaughters more susceptible to stress 2
... MADISON - In mice, child neglect is a product of ... Writing in the journal PLoS ONE on April 9, researchers ... that exhibit unusually high rates of maternal neglect, with approximately ... her offspring. By comparing the good mothers to their ...
... fraction of the 3 billion letter DNA code actually instructs ... This has raised the question of what the remaining part ... performs other biological functions, and how much is merely residue ... Laboratory (CSHL) and the University of Chicago now report that ...
... 2008 More good news for pistachio fans! According to ... in San Diego, snacking on pistachios has proved once again ... significantly reducing inflammation in the body, a prominent cardiovascular disease ... cause of death in the U.S., with millions more Americans ...
Cached Biology News:Negligent, attentive mouse mothers show biological differences 2Negligent, attentive mouse mothers show biological differences 3Scientists find a fingerprint of evolution across the human genome 2Nutrition research unveiled this week shows pistachios are smart for the heart 2Nutrition research unveiled this week shows pistachios are smart for the heart 3Nutrition research unveiled this week shows pistachios are smart for the heart 4
... Western blotting is a commonly used ... Typically, protein samples are electrophoresed on SDS-PAGE ... nitrocellulose or nylon, where they are probed ... technologies, which allow reuse of Southern and ...
... ProXPRESS 2D Proteomic Imaging System, Basic Package ... a Wide Dynamic Range: The ProXPRESS 2D ... in imaging system for both proteomic and ... provides unparalleled flexibility, enabling the use of ...
... Introducing our Regulatory Edition of Molecular Imaging ... systems for life science research and drug ... compliance with U.S. Food and Drug Administrations ... 11 Electronic Records; Electronic Signatures [21 CFR ...
... OPA1-01009, OPEP-01009 is a 16 amino acid (amino acids 3-18) ... (DFF). The sequence of this peptide is (amino to ... S - V - K - L - R - ... R - K(18). This peptide may be used ...
Biology Products: